Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

By sjmartinez • January 7, 2023

Nicholas SB, Alicic RZ, Shen J. Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States. Kidney Med. 2022 Dec 15;5(1):100590. doi: 10.1016/j.xkme.2022.100590. PMID: 36605084; PMCID: PMC9807823.

Tags: Harbor UCLA, Nephrology, Publications

SPIROMICS HF: Rationale, Design, and Reproducibility of Measures

Barr RG, Lima JAC, Prince MR, Ambale Venkatesh B, Abraham T, Agarwal PP, Arora G, Balasubramanian A, Barjaktarevic I, Bello NA, Bluemke DA, Budoff MJ,[...]

Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis

García-Sarreón A, Martinez-Lopez Y, Gómez-Figueroa E, Rivas-Alonso V, Flores J, Behne JM, Yeaman MR, Smith TJ, Behne MK, Delgado-Garcia G, Corona T. Patient-reported quality of[...]

Sex Differences in Aortic Arch Calcification With Zero Coronary Artery Calcium

Joshi MA, Manubolu VS, Kinninger A, Wang R, McClelland RL, Roy SK, Budoff MJ. Sex Differences in Aortic Arch Calcification With Zero Coronary Artery Calcium.[...]